Novozymes has announced the company will build a new research and development center located near the Research Triangle in Park in Cary, North Carolina dedicated to bioagriculture business. The company will invest nearly $36 million over the next three years and create 100 new research and development jobs.

“The world needs sustainable agricultural solutions now more than ever before. By boosting our research and development of environmentally-friendly microbial technology, we will help farmers meet this demand sooner rather than later,” said Thomas Videbaek, Executive Vice President of Business Development. “The new R&D center in North Carolina is a concrete step to help speed our technology to market from a state with a long history of agricultural innovation.”

Scientists at the new site in North Carolina will research and develop beneficial microorganisms found in the soil. The resulting technology will focus on improved crop yield, fertility and pest control for growers around the world. The company says the significant expansion of R&D resources will enable Novozymes’ scientists to pursue more and better biological solutions for the ever-changing challenges facing global agriculture.

“Novozymes and North Carolina have been good partners since we opened the doors to our North American headquarters here in 1979,” said Adam Monroe, President, Americas. “We look forward to opening our new facility in a state that has worked hand in hand with us over the years to help our business thrive.”